Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07220060 ADME study in healthy adults
NL-OMON59250Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of atirmociclib, sponsored by Pfizer. Started Jan 2024; status: completed.
02
Drugs
atirmociclib
Beyond the preview
Go deeper on NL-OMON59250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59250.